Products

PIEX - plant-identical extracts for cannabis therapies

Cannabis extracts as active pharmaceutical ingredients and medicinal products

PIEX stands for plant-identical cannabis extracts that are available both as active pharmaceutical ingredients and as prescription drugs. With our unique extraction technology, we obtain the natural ratio of cannabinoids and terpenes from the cannabis flower, making the selection of the flower the first quality criterion for our products. 

We are the only EU-GMP manufacturer to offer quantified terpene profiles that go beyond the THC:CBD monographs and make terpenes a complementary criterion for extract therapies.

2 + 5: more data in the extended certificate of analysis (CoA)

In addition to the THC:CBD monograph, PIEX extracts always have a stable, specific terpene profile, which is shown in the extended certificate of analysis (CoA) based on the 5 lead terpenes. They represent over 75% of the total terpene content of the flower and enable doctors to control cannabis therapies more precisely on the basis of the extended data situation and to adapt them to the individual needs of patients.

PIEX - Active pharmaceutical ingredients

In addition to their unique terpene profile, our plant-identical cannabis crude extracts with 70% THC have a very manageable viscosity. This enables precise dosing and easy processing of our crude extracts. The comprehensive cannabinoid and terpene profiles of PIEX extracts can also have a positive effect on the tolerability and aroma of the respective medicinal product due to synergistic effect. This is a particular advantage for oral medication.

  • Applications: Tinctures, oils, capsules, topical preparations, vaping preparations
  • Special feature: different terpene profiles (quantified in the extended CoA)

PIEX - Medicines

Our adjusted PIEX extracts offer quantified terpene profiles beyond the monograph as supplementary criteria for patient-specific extract therapies. With THC:CBD concentrations ranging from 2.5% to 25%, our extracts offer the known variance from THC dominant to balanced to CBD dominant. In addition, each of our PIEX medicinal products has a precise terpene profile, which is shown using the 5 lead terpenes in the extended CoA.

  • Availability: various active ingredient strengths (2.5% up to 25%)
  • Special feature: different terpene profiles (quantified in the extended CoA)

Production in Germany

Our portfolio is manufactured in our own production facility in Berlin. As a GMP-certified production facility, we offer the development, filling and batch release of medicinal products and active pharmaceutical ingredients as well as the packaging of the corresponding products as a CDMO.